JPWO2021193790A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021193790A5 JPWO2021193790A5 JP2022510640A JP2022510640A JPWO2021193790A5 JP WO2021193790 A5 JPWO2021193790 A5 JP WO2021193790A5 JP 2022510640 A JP2022510640 A JP 2022510640A JP 2022510640 A JP2022510640 A JP 2022510640A JP WO2021193790 A5 JPWO2021193790 A5 JP WO2021193790A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- compound
- hydrogen atom
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020056826 | 2020-03-26 | ||
| JP2020056826 | 2020-03-26 | ||
| JP2020133635 | 2020-08-06 | ||
| JP2020133635 | 2020-08-06 | ||
| PCT/JP2021/012446 WO2021193790A1 (ja) | 2020-03-26 | 2021-03-25 | セロトニン受容体結合活性を有する芳香族複素環誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021193790A1 JPWO2021193790A1 (https=) | 2021-09-30 |
| JPWO2021193790A5 true JPWO2021193790A5 (https=) | 2024-03-19 |
| JP7853902B2 JP7853902B2 (ja) | 2026-04-30 |
Family
ID=77890488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510640A Active JP7853902B2 (ja) | 2020-03-26 | 2021-03-25 | セロトニン受容体結合活性を有する芳香族複素環誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12527775B2 (https=) |
| JP (1) | JP7853902B2 (https=) |
| CN (1) | CN115605202B (https=) |
| TW (1) | TW202202491A (https=) |
| WO (1) | WO2021193790A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022017440A1 (zh) * | 2020-07-22 | 2022-01-27 | 山东绿叶制药有限公司 | 5-ht 2a受体抑制剂或反向激动剂及其制备方法和应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802206B1 (fr) * | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| RU2002126554A (ru) | 2000-03-06 | 2004-03-20 | Акадиа Фармасьютикалз, Инк. (Us) | Азациклические соединения для применения при лечении опосредованных серотонином заболеваний |
| WO2003057698A2 (en) | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Spiroazacyclic compounds as monoamine receptor modulators |
| ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
| CN100509804C (zh) * | 2002-06-24 | 2009-07-08 | 阿卡蒂亚药品公司 | N-取代哌啶衍生物作为血清素受体试剂 |
| PT1587789E (pt) | 2003-01-16 | 2008-12-16 | Acadia Pharm Inc | Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas |
| US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| WO2007124136A1 (en) | 2006-04-19 | 2007-11-01 | Acadia Pharmaceuticals, Inc. | Use of 4-amino-piperidines for treating sleep disorders |
| WO2009039461A2 (en) | 2007-09-21 | 2009-03-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| WO2010111353A1 (en) | 2009-03-25 | 2010-09-30 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| EP3569233A4 (en) | 2017-01-13 | 2020-09-30 | Sumitomo Dainippon Pharma Co., Ltd. | THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE |
| CN109111385B (zh) | 2017-06-23 | 2023-06-30 | 上海翰森生物医药科技有限公司 | 5-ht2a受体抑制剂及其制备方法和应用 |
| SG11202001062XA (en) | 2017-08-21 | 2020-03-30 | Acadia Pharm Inc | Compounds, salts thereof and methods for treatment of diseases |
| WO2019040106A2 (en) | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES |
| WO2019040104A2 (en) | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | COMPOUNDS, RELATED SALTS AND METHODS OF TREATING DISEASES |
| WO2019040105A2 (en) | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES |
| CN113214141B (zh) | 2020-01-21 | 2022-04-08 | 瀚远医药有限公司 | 5ht2a受体拮抗剂及其制备和应用 |
| WO2021147818A1 (zh) | 2020-01-21 | 2021-07-29 | 瀚远医药有限公司 | 5-ht2a受体拮抗剂及其治疗中枢神经系统疾病的应用 |
| CN113214289B (zh) | 2020-01-21 | 2022-10-28 | 瀚远医药有限公司 | 5-ht2a受体拮抗剂及其治疗中枢神经系统疾病的应用 |
| CN113214231B (zh) | 2020-01-21 | 2022-04-08 | 瀚远医药有限公司 | 5ht2a受体拮抗剂及其医疗应用 |
| JP7693709B2 (ja) | 2020-04-26 | 2025-06-17 | ジャンスー・エンファ・ファーマシューティカル・カンパニー・リミテッド | １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 |
| CN113549006B (zh) | 2020-04-26 | 2023-07-21 | 江苏恩华药业股份有限公司 | 一种酰胺衍生物及其应用 |
| WO2022017440A1 (zh) | 2020-07-22 | 2022-01-27 | 山东绿叶制药有限公司 | 5-ht 2a受体抑制剂或反向激动剂及其制备方法和应用 |
-
2021
- 2021-03-25 CN CN202180038091.6A patent/CN115605202B/zh active Active
- 2021-03-25 JP JP2022510640A patent/JP7853902B2/ja active Active
- 2021-03-25 WO PCT/JP2021/012446 patent/WO2021193790A1/ja not_active Ceased
- 2021-03-25 US US17/913,378 patent/US12527775B2/en active Active
- 2021-03-26 TW TW110111147A patent/TW202202491A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6850922B2 (ja) | Ｊａｋキナーゼ阻害剤としてのナフチリジン化合物 | |
| EP3555063B1 (en) | 6-amino-quinolinone compounds and derivatives as bcl6 inhibitors | |
| KR102479789B1 (ko) | 이중 lsd1/hdac 억제제로서 사이클로프로필-아마이드 화합물 | |
| TWI801378B (zh) | 作為tnf活性調節劑之稠合五環咪唑衍生物 | |
| JP7464920B2 (ja) | 免疫調節としての芳香環誘導体及びその製造方法と使用 | |
| TW502024B (en) | A tricyclic pyridazole derivative | |
| JP2021523875A (ja) | Ｆｇｆｒ阻害剤としてのピラジン−２（１ｈ）−オン系化合物 | |
| SE463210B (sv) | Azabicykliska estrar och amider, foerfarande foer framstaellning av dessa och en farmaceutisk komposition | |
| JPH04500665A (ja) | ５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類 | |
| CA2934953A1 (en) | Substituted pyrido[3,2-b]indoyl compounds and pharmaceutical compositions thereof as anticancer agents | |
| CA2599876A1 (en) | Peptidomimetic compounds and preparation of biologically active derivatives | |
| EP0797576A1 (en) | Alkyl substituted piperadinyl and piperazinyl anti-aids compounds | |
| JPWO2021193790A5 (https=) | ||
| JP2020509013A (ja) | スピロ化合物およびその使用 | |
| JP5121703B2 (ja) | エルゴリン誘導体およびケモカイン受容体リガンドとしてのそれらの使用 | |
| AU2025223941A1 (en) | Compounds | |
| IL309069A (en) | CXCR4 cytokine receptor modulators and related uses | |
| Kubas et al. | Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators | |
| JP4699027B2 (ja) | 新規なアリール−｛４−ハロ−４−〔（ヘテロアリールメチルアミノ）メチル〕ピペリジン−１−イル｝メタノン誘導体、その製造方法および医薬としてのその使用 | |
| JP2024500179A (ja) | ピロール誘導体、その調製方法及びその用途 | |
| JPWO2018097295A1 (ja) | ピリド［３，４−ｄ］ピリミジン誘導体又はその溶媒和物の結晶 | |
| Zunszain et al. | Tritylamino Aromatic Heterocycles and Related Carbinols as Blockers of Ca 2+‐Activated Potassium Ion Channels Underlying Neuronal Hyperpolarization | |
| DK142200B (da) | Analogifremgangsmåde til fremstilling af 14-substituerede vincanderivater eller syreadditionssalte eller kvaternære salte deraf. | |
| JPS63225354A (ja) | アゼチジノン誘導体 | |
| US12156880B2 (en) | Heterocyclic RIP1 kinase inhibitors |